4//SEC Filing
Piacquad David 4
Accession 0001610717-23-000285
CIK 0001885522other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:56 PM ET
Size
5.2 KB
Accession
0001610717-23-000285
Insider Transaction Report
Form 4
Piacquad David
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-09-14+46,455→ 46,455 totalExercise: $17.00Exp: 2033-09-13→ Common Stock (46,455 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option vest on each monthly anniversary measured from September 8, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.
Documents
Issuer
Neumora Therapeutics, Inc.
CIK 0001885522
Entity typeother
Related Parties
1- filerCIK 0001602343
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 5:56 PM ET
- Size
- 5.2 KB